Home › Pulmonary Hypertension › Minnesota › Minneapolis
Pulmonary Hypertension clinical trials in Minneapolis, MN
4 studies for Pulmonary Hypertension are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Minneapolis Heart Institute, Minneapolis
Pulmonary Hypertension Association Registry
RecruitingObservational study
- University of Minnesota Health, Minneapolis
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Recruiting
- University of Minnesota, Minneapolis
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Phoenix, AZ9 studies
- Aurora, CO9 studies
- Kansas City, KS8 studies
- New York City, NY8 studies
- Cincinnati, OH8 studies
- Boston, MA8 studies
- Indianapolis, IN8 studies
- Bend, OR7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
- Rochester, MN7 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.